Register or Login
  • All
  • Uniprot Id
  • Catalog #
  • Peptide Sequence
>   home   >   Products   >   Peptides   >   Blocking Peptides   >   HDBP2(HDRF-2) Antibody (Center) Blocking Peptide   

HDBP2(HDRF-2) Antibody (Center) Blocking Peptide

Synthetic peptide

Product Information
Primary Accession Q9H8N7
Other Accession NP_061130
Clone Names 6020666
Additional Information
Other Names Zinc finger protein 395, HD-regulating factor 2, HDRF-2, Huntington disease gene regulatory region-binding protein 2, HD gene regulatory region-binding protein 2, HDBP-2, Papillomavirus regulatory factor 1, PRF-1, Papillomavirus-binding factor, ZNF395, HDBP2, PBF
Target/Specificity The synthetic peptide sequence used to generate the antibody AP1979c was selected from the HDRF-2 region of human HDBP2(HDRF-2). A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
StorageMaintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
PrecautionsThis product is for research use only. Not for use in diagnostic or therapeutic procedures.
Protein Information
Name ZNF395
Synonyms HDBP2, PBF
Function Plays a role in papillomavirus genes transcription.
Cellular Location Cytoplasm. Nucleus. Note=May shuttle between nucleus and cytoplasm
Tissue Location Widely expressed. EMBL; AF263928; AAF73463.1; -; mRNA EMBL; AB044750; BAA96783.1; -; mRNA EMBL; AB044751; BAA96784.1; -; mRNA EMBL; AB044752; BAA96785.1; -; mRNA EMBL; AB057659; BAB39851.1; -; mRNA EMBL; AB073627; BAD29734.1; -; mRNA EMBL; AK002050; BAA92056.1; -; mRNA EMBL; AK023418; BAB14571.1; -; mRNA EMBL; AK098243; BAG53599.1; -; mRNA EMBL; CH471080; EAW63519.1; -; Genomic_DNA EMBL; CH471080; EAW63521.1; -; Genomic_DNA EMBL; CH471080; EAW63522.1; -; Genomic_DNA EMBL; CH471080; EAW63523.1; -; Genomic_DNA EMBL; CH471080; EAW63524.1; -; Genomic_DNA EMBL; BC001237; AAH01237.1; -; mRNA CCDS; CCDS6067.1; - RefSeq; NP_061130.1; NM_018660.2 SMR; Q9H8N7; - BioGRID; 120983; 7 IntAct; Q9H8N7; 5 MINT; Q9H8N7; - STRING; 9606.ENSP00000340494; - iPTMnet; Q9H8N7; - PhosphoSitePlus; Q9H8N7; - BioMuta; ZNF395; - DMDM; 84028224; - EPD; Q9H8N7; - jPOST; Q9H8N7; - MassIVE; Q9H8N7; - MaxQB; Q9H8N7; - PaxDb; Q9H8N7; - PeptideAtlas; Q9H8N7; - PRIDE; Q9H8N7; - ProteomicsDB; 81230; - Antibodypedia; 10391; 213 antibodies DNASU; 55893; - Ensembl; ENST00000344423; ENSP00000340494; ENSG00000186918 Ensembl; ENST00000523095; ENSP00000428452; ENSG00000186918 Ensembl; ENST00000523202; ENSP00000429640; ENSG00000186918 GeneID; 55893; - KEGG; hsa:55893; - UCSC; uc003xgq.4; human CTD; 55893; - DisGeNET; 55893; - EuPathDB; HostDB:ENSG00000186918.13; - GeneCards; ZNF395; - HGNC; HGNC:18737; ZNF395 HPA; ENSG00000186918; Low tissue specificity MIM; 609494; gene neXtProt; NX_Q9H8N7; - OpenTargets; ENSG00000186918; - PharmGKB; PA134978145; - eggNOG; ENOG502QW7P; Eukaryota GeneTree; ENSGT00940000157136; - HOGENOM; CLU_032989_2_1_1; - InParanoid; Q9H8N7; - OMA; CCRVEEV; - OrthoDB; 915379at2759; - PhylomeDB; Q9H8N7; - TreeFam; TF326610; - PathwayCommons; Q9H8N7; - BioGRID-ORCS; 55893; 11 hits in 877 CRISPR screens ChiTaRS; ZNF395; human GenomeRNAi; 55893; - Pharos; Q9H8N7; Tbio PRO; PR:Q9H8N7; - Proteomes; UP000005640; Chromosome 8 RNAct; Q9H8N7; protein Bgee; ENSG00000186918; Expressed in amniotic fluid and 238 other tissues ExpressionAtlas; Q9H8N7; baseline and differential Genevisible; Q9H8N7; HS GO; GO:0005737; C:cytoplasm; IDA:UniProtKB GO; GO:0005829; C:cytosol; IDA:HPA GO; GO:0005654; C:nucleoplasm; IDA:HPA GO; GO:0005634; C:nucleus; IDA:UniProtKB GO; GO:0003677; F:DNA binding; IDA:UniProtKB GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:Ensembl GO; GO:0006355; P:regulation of transcription, DNA-templated; IC:UniProtKB InterPro; IPR031940; DUF4772 InterPro; IPR013087; Znf_C2H2_type Pfam; PF15997; DUF4772; 1 PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1 PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1 1: Evidence at protein level; Cytoplasm; DNA-binding; Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription; Transcription regulation; Zinc; Zinc-finger CHAIN 1..513 /note="Zinc finger protein 395" /id="PRO_0000047561" ZN_FING 280..305 /note="C2H2-type" /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" MOTIF 165..174 /note="Nuclear export signal" /evidence="ECO:0000255" MOD_RES 248 /note="Phosphoserine" /evidence="ECO:0000244|PubMed:19690332" MOD_RES 376 /note="Phosphoserine" /evidence="ECO:0000244|PubMed:24275569" MOD_RES 449 /note="Phosphoserine" /evidence="ECO:0000244|PubMed:23186163" MUTAGEN 109 /note="L->A: No change in subcellular location; when associated with A-113." /evidence="ECO:0000269|PubMed:14625278" MUTAGEN 113 /note="L->A: No change in subcellular location; when associated with A-109." /evidence="ECO:0000269|PubMed:14625278" MUTAGEN 169 /note="M->A: No shuttle from the nucleus to the cytoplasm; when associated with A-172." /evidence="ECO:0000269|PubMed:14625278" MUTAGEN 172 /note="M->A: No shuttle from the nucleus to the cytoplasm; when associated with A-169." /evidence="ECO:0000269|PubMed:14625278" CONFLICT 140 /note="G -> R (in Ref. 2; BAA96783/BAD29734)" /evidence="ECO:0000305" CONFLICT 464 /note="L -> Q (in Ref. 3; BAB14571)" /evidence="ECO:0000305" SEQUENCE 513 AA; 54939 MW; 992990499E228EB8 CRC64; MASVLSRRLG KRSLLGARVL GPSASEGPSA APPSEPLLEG AAPQPFTTSD DTPCQEQPKE VLKAPSTSGL QQVAFQPGQK VYVWYGGQEC TGLVEQHSWM EGQVTVWLLE QKLQVCCRVE EVWLAELQGP CPQAPPLEPG AQALAYRPVS RNIDVPKRKS DAVEMDEMMA AMVLTSLSCS PVVQSPPGTE ANFSASRAAC DPWKESGDIS DSGSSTTSGH WSGSSGVSTP SPPHPQASPK YLGDAFGSPQ TDHGFETDPD PFLLDEPAPR KRKNSVKVMY KCLWPNCGKV LRSIVGIKRH VKALHLGDTV DSDQFKREED FYYTEVQLKE ESAAAAAAAA AGTPVPGTPT SEPAPTPSMT GLPLSALPPP LHKAQSSGPE HPGPESSLPS GALSKSAPGS FWHIQADHAY QALPSFQIPV SPHIYTSVSW AAAPSAACSL SPVRSRSLSF SEPQQPAPAM KSHLIVTSPP RAQSGARKAR GEAKKCRKVY GIEHRDQWCT ACRWKKACQR FLD
Research Areas
Citations (0)

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.

Submit your citation using an Abcepta antibody to, and receive a free "I Love Antibodies" mug.


Papillomavirus Regulatory Factor 1/HDBP2 is a novel transcription factor shuttling between nucleus and cytoplasm and binds to the specific GCCGGCG, which is an essential cis-element for Huntington's disease gene expression.


Tanaka,K., J. Biol. Chem. 279 (8), 7275-7286 (2004)

Abcepta welcomes feedback from its customers.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.

If you have any additional inquiries please email technical services at

$ 277.78
Cat# BP1979c
Availability: 2 weeks
Bulk Size

Ordering Information

United States
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaCentral AmericaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSouth KoreaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamWorldwideOthers
Abcepta, Inc.
(888) 735-7227 / (858) 622-0099
(858) 622-0609
USA Headquarters
(888) 735-7227 / (858) 622-0099 or (858) 875-1900
Cedarlane Labs
+1 (800) 721-1644
+1 (336) 513-5138

Shipping Information

Domestic orders (in stock items)
Shipped out the same day. Orders placed after 1 PM (PST) will ship out the next business day.
International orders
Contact your local distributors
Terms & Conditions